Shire Human Genetic Therapies Development and Acquisition of Lexington Technology Park

Representation of Shire Human Genetic Therapies, Inc. in connection with the development and acquisition of the 95-acre Lexington Technology Park in Lexington, MA, including negotiation of two space leases, two reverse build-to-suit leases for new facilities, an option agreement giving Shire control of the site and rights of first offer to lease or purchase, the acquisition of a parcel in the park on which Shire constructed a new biotech manufacturing facility, and all related architectural services and construction contracts for the design and construction of such facilities.